Phreesia Corp (PHR) - Company Value to Net Income

Corporate emblem and logo of Phreesia Corp (PHR)

Phreesia, Inc. (PHR) maintains a flawless reputation as a digital administrator among US clinics. The issuer's P/E ratio reflects market expectations, with the current metric standing at 76.30. Revenues are based on cloud subscriptions for payment and registration automation. The integration of software into healthcare infrastructure creates a critical dependency of back offices on the company's ecosystem, ensuring stable business growth.

Phreesia Corp (PHR) - P/E Multiple from 07/04/2022 to 11/12/2026

Analytical breakdowns for Phreesia, Inc.

- stock price and consensus target price:
Quote Chart phreesia.com|PHR - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Phreesia, Inc.|PHR - Total Company Value
- balance sheet net asset value indicators:
Accounting Value of a Share Phreesia|PHR - Book Capitalization|Market-to-Book Ratio phreesia.com|PHR - Company Total Assets
- company liabilities and liquidity data:
Debt to Capital Phreesia, Inc.|PHR - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Phreesia Health|PHR - Company Aggregate Debts|Debts to Net Assets Phreesia, Inc.|PHR - Company Long-Term Debts|Company Short-Term Debts Phreesia|Intermediate Coverage Ratio phreesia.com
- earnings and valuation multiples indicators:
PHR - Net Profit|Company Profit Forecast Phreesia, Inc.|PHR - Price to Earnings Ratio|Price to Future Earnings Ratio Phreesia Inc|PHR - PEG Multiple|Enterprise Value to EBITDA Ratio Phreesia, Inc.|PHR - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Phreesia|PHR - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months phreesia.com|PHR - Earnings growth in current year|Expected earnings per share trend next year Phreesia, Inc.
Summary company analysis:Phreesia, Inc.
Original product of Phreesia, Inc.

This indicator determines the investment payback period by comparing the stock's market value with net income from the previous period to assess the asset's fundamental overbought status. By analyzing the calculated price-to-earnings multiple, an investor can evaluate how effectively medical payment automation and advertising contracts with pharma behemoths convert revenue into real income, confirming the capital stability of Phreesia, Inc. (PHR).

Key competitors

veeva.com - Market Cap to Net Income|P/E Multiple DOCS|HQY (HealthEquity Inc) - Company Value to Net Income|Price to Earnings Ratio Waystar Inc. WAY|Company Value to Net Income CRVL|Privia Health Group - P/E Multiple|Market Cap to Earnings huronconsultinggroup.com|CERT: P/E Multiple|Market Cap to Earnings Omnicell Inc (OMCL)|Price to Earnings Ratio GoodRx Corp|Schrodinger Corp (SDGR) - Business Payback Period|P/E Multiple OMDA|Business Payback Period evolenthealth.com|P/E Multiple HSTM (HealthStream)|P/E Multiple Definitive Healthcare Corp DH|CCSI: Price to Earnings Ratio|Company Value to Net Income AGL (Agilon Health Corp)|ABSI: P/E Multiple|SY - Business Payback Period|Price to Earnings Ratio National Research Corporation|Price to Earnings Multiple SPOK (Spok Holdings Inc)|P/E Multiple OPRX|Price to Earnings Ratio TruBridge Corp TBRG|Simulations Plus, Inc. - Price to Earnings Ratio|Business Payback Period Sophia Genetics (SOPH)|HCAT - Price to Earnings Ratio|Market Cap to Net Income CCLD|RSSS: P/E Multiple|DLH Holdings - Company Value to Net Income|Price to Earnings Ratio OneMedNet Corp|SCNX: Company Value to Net Income|P/E Multiple HCTI|Business Payback Period ispecimen.com|Bullfrog AI - Price to Earnings Ratio|Market Price to Net Income Ratio WORX (SCWorx Inc)|MSPR: Price to Earnings Ratio|Company Value to Net Income ICCT (iCoreConnect Inc.)|TRxADE HEALTH (MEDS) - Price to Earnings Ratio|Price to Earnings Ratio Orgenesis Inc|RCM (R1 RCM, Inc.) - P/E Multiple|Market Cap to Earnings Sharecare Inc SHCR|P/E Multiple STRM|syrahealth.com - Price to Earnings Multiple|Price to Earnings Ratio Apollo Medical Holdings, Inc. AMEH|MODN (Model N Inc) - Market Cap to Net Income|NextGen - P/E Multiple